Teva Resolves Glaxo IP Suit Over Generic Combivir
GlaxoSmithKline PLC unit Glaxo Group Ltd. has settled its suit accusing Israel-based generics maker Teva Pharmaceuticals USA Inc. of patent infringement for planning to make its own version of HIV drug...To view the full article, register now.
Already a subscriber? Click here to view full article